NCT06972862

Brief Summary

The goal of this clinical trial is to evaluate how different exercise programs alter bone density, structure, and strength in adults. It will also collect data on hormones, factors released from skeletal muscle, and body composition. The main questions it aims to answer are:

  • Do exercise programs that are frequent with high-impact loading will cause greater improvements in bone health?
  • What changes in hormones, factors released from skeletal muscle, and body composition contribute to bone adaptations? Researchers will compare different exercise groups to see if the type of exercise influences bone adaptation compared to a recreationally active control group. Participants are asked to:
  • complete questionnaires, 5 blood draws across the study (3 at rest, 2 after strenuous exercise), dual energy x-ray absorptiometry (DXA) scans (to assess bone mineral density and body composition), high resolution tibial scans to assess bone structure and geometry, and physical performance testing.
  • attend up to 7 testing visits.
  • (for those randomized to the exercise training intervention) participate in exercise training sessions for 6 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 29, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 27, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 28, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 15, 2025

Completed
Last Updated

May 15, 2025

Status Verified

April 1, 2025

Enrollment Period

2.7 years

First QC Date

April 28, 2025

Last Update Submit

May 6, 2025

Conditions

Keywords

bone healthbody compositionskeletal musclehormonesexercise interventionrecreational athletesbone marrow adipose tissuebone formationbone resportionbone geometrybone microarchitecturebone mineral density

Outcome Measures

Primary Outcomes (2)

  • Bone microarchitecture: Change in bone microarchitecture as measured via High Resolution- peripheral Quantitative Computed Tomography, change from baseline, mean

    Through study completion, an average of 6 months.

  • Bone strength: Change in bone strength as measured via High Resolution- peripheral Quantitative Computed Tomography, change from baseline, mean

    Through study completion, an average of 6 months

Secondary Outcomes (8)

  • Biochemical: Change in concentration of Bone alkaline phosphatase (BAP), change from baseline, mean

    Through study completion, an average of 6 months

  • Biochemical: Change in concentration of Procollagen type I N-terminal Propeptide (P1NP), change from baseline, mean

    Through study completion, an average of 6 months

  • Biochemical: Change in concentration of Tartrate-resistant acid phosphatase 5b (TRAP5b), change from baseline, mean

    Through study completion, an average of 6 months

  • Biochemical: Change in concentration of Beta Cross-linking Telopeptide of type I (B-CTx) collagen, change form baseline, mean

    Through study completion, an average of 6 months

  • Bone characteristics: Change in amount of Bone Marrow Adipose Tissue, change from baseline, mean

    Through study completion, an average of 6 months

  • +3 more secondary outcomes

Other Outcomes (2)

  • Body composition: Change in Dual Energy X-Ray Absorptiometry lean mass, change from baseline, mean

    Through study completion, an average of 6 months

  • Bone characteristics: Change in Areal Bone Mineral Density, change from baseline, mean

    Through study completion, an average of 6 months

Study Arms (3)

Laboratory Based Osteogenic Index (OI) Optimized Training Group

EXPERIMENTAL

The OI- Optimized Training Group will involve 6 months of planned, non-linear periodized training on a leg press machine called the PPM (Athletic Republic, Salt Lake City, UT) with a maintenance program during the semester breaks, as necessary.

Other: Osteogenic Index Optimized Exercise Training Program

Laboratory Based Control Group

NO INTERVENTION

The control group will maintain their habitual exercise, diet, and sleep patterns, all of which will be monitored throughout the study.

Reserve Officer Training Corps (ROTC): Observational Group

NO INTERVENTION

The ROTC group is made up of Reserve Officer Training Corps participants who are attending a university while concurrently undergoing militaristic training. This group will maintain their physical training as part of their program, diet, and sleep patterns which are monitored throughout the study.

Interventions

The OI- Optimized Training is 6 months of planned, non-linear periodized training on a leg press machine called the PPM (Athletic Republic, Salt Lake City, UT) with a maintenance program during the semester breaks, as necessary.

Also known as: Exercise Intervention
Laboratory Based Osteogenic Index (OI) Optimized Training Group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-40 years
  • Body mass index (BMI) 18-28 kg/m2
  • Weight stable (±10 lbs) in past 2 months
  • Takes part in moderate physical activity for at least 150 minutes/week
  • Currently free of upper or lower body /extremity injury or impairment
  • Comfortable with multiple blood draws
  • Able to commit to the 6-month study duration
  • Agrees to adhere to study requirements.

You may not qualify if:

  • Current smoker
  • Current clinical diagnosis of an eating disorder
  • Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs). NSAID use is defined as chronic if these medications are taken more than three times a week for more than 12 consecutive weeks.
  • Use of medication incompatible with measurement of reproductive, metabolic, or bone-related hormones (including thyroid medications, glucocorticoids) or which includes anti-coagulants and may interfere with any of the study outcomes
  • Current oligo/amenorrhea in women, not explained by contraceptive use
  • Any metabolic or endocrine disease that affects bone; Individuals taking hormonal therapy for transgender care
  • Currently training for a competitive sporting event or planning to start
  • Weight has fluctuated by 10 pounds or more in the past 2 months based on subject self-report
  • Has been diagnosed with a medical condition, physical or psychological, that currently prevents exercise participation
  • Has suffered a musculoskeletal injury removing them from physical activity for more than a month, within the past two years
  • Currently pregnant or becomes pregnant during the study (as assessed by urine pregnancy tests at 0, 3 \& 6 months)
  • Current asthma diagnosis, defined as experienced symptoms or been prescribed any form of treatment within the last 4 years, or those who have required more than one course of oral steroids or more than one nebulization since the age of 5 (JSP 950), will require a note/permission from treating physician to participate in study. Those who have had a single admission to intensive care or high dependency, or multiple admissions to hospital will be excluded from participating (JSP 950)
  • History of heart condition OR high blood pressure
  • Feeling of pain in the chest during rest, activities of daily living, or physical activity
  • Have lost balance or consciousness due to dizziness in the last 12 months (with the exception of dizziness due to hyperventilation)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Kansas, Jayhawk Performance Laboratory

Lawrence, Kansas, 66045, United States

Location

Neuromuscular Research Laboratory

Pittsburgh, Pennsylvania, 15203, United States

Location

Related Publications (15)

  • Allaway HC, Williams NI, Mallinson RJ, Koehler K, De Souza MJ. Reductions in urinary collection frequency for assessment of reproductive hormones provide physiologically representative exposure and mean concentrations when compared with daily collection. Am J Hum Biol. 2015 May-Jun;27(3):358-71. doi: 10.1002/ajhb.22649. Epub 2014 Oct 29.

    PMID: 25353669BACKGROUND
  • Nindl BC, Urso ML, Pierce JR, Scofield DE, Barnes BR, Kraemer WJ, Anderson JM, Maresh CM, Beasley KN, Zambraski EJ. IGF-I measurement across blood, interstitial fluid, and muscle biocompartments following explosive, high-power exercise. Am J Physiol Regul Integr Comp Physiol. 2012 Nov 15;303(10):R1080-9. doi: 10.1152/ajpregu.00275.2012. Epub 2012 Aug 29.

    PMID: 22933025BACKGROUND
  • Lester ME, Urso ML, Evans RK, Pierce JR, Spiering BA, Maresh CM, Hatfield DL, Kraemer WJ, Nindl BC. Influence of exercise mode and osteogenic index on bone biomarker responses during short-term physical training. Bone. 2009 Oct;45(4):768-76. doi: 10.1016/j.bone.2009.06.001. Epub 2009 Jun 9.

    PMID: 19520194BACKGROUND
  • Carson JA, Manolagas SC. Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease. Bone. 2015 Nov;80:67-78. doi: 10.1016/j.bone.2015.04.015.

    PMID: 26453497BACKGROUND
  • Wentz L, Liu PY, Haymes E, Ilich JZ. Females have a greater incidence of stress fractures than males in both military and athletic populations: a systemic review. Mil Med. 2011 Apr;176(4):420-30. doi: 10.7205/milmed-d-10-00322.

    PMID: 21539165BACKGROUND
  • Rantalainen T, Nikander R, Heinonen A, Cervinka T, Sievanen H, Daly RM. Differential effects of exercise on tibial shaft marrow density in young female athletes. J Clin Endocrinol Metab. 2013 May;98(5):2037-44. doi: 10.1210/jc.2012-3748. Epub 2013 Apr 24.

    PMID: 23616150BACKGROUND
  • Singhal V, Torre Flores LP, Stanford FC, Toth AT, Carmine B, Misra M, Bredella MA. Differential associations between appendicular and axial marrow adipose tissue with bone microarchitecture in adolescents and young adults with obesity. Bone. 2018 Nov;116:203-206. doi: 10.1016/j.bone.2018.08.009. Epub 2018 Aug 11.

    PMID: 30107255BACKGROUND
  • Gorgey AS, Poarch HJ, Adler RA, Khalil RE, Gater DR. Femoral bone marrow adiposity and cortical bone cross-sectional areas in men with motor complete spinal cord injury. PM R. 2013 Nov;5(11):939-48. doi: 10.1016/j.pmrj.2013.05.006. Epub 2013 May 15.

    PMID: 23684921BACKGROUND
  • Sanford JA, Nogiec CD, Lindholm ME, Adkins JN, Amar D, Dasari S, Drugan JK, Fernandez FM, Radom-Aizik S, Schenk S, Snyder MP, Tracy RP, Vanderboom P, Trappe S, Walsh MJ; Molecular Transducers of Physical Activity Consortium. Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise. Cell. 2020 Jun 25;181(7):1464-1474. doi: 10.1016/j.cell.2020.06.004.

    PMID: 32589957BACKGROUND
  • Whitham M, Parker BL, Friedrichsen M, Hingst JR, Hjorth M, Hughes WE, Egan CL, Cron L, Watt KI, Kuchel RP, Jayasooriah N, Estevez E, Petzold T, Suter CM, Gregorevic P, Kiens B, Richter EA, James DE, Wojtaszewski JFP, Febbraio MA. Extracellular Vesicles Provide a Means for Tissue Crosstalk during Exercise. Cell Metab. 2018 Jan 9;27(1):237-251.e4. doi: 10.1016/j.cmet.2017.12.001.

    PMID: 29320704BACKGROUND
  • Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, Gulseth HL, Birkeland KI, Jensen J, Drevon CA. The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2014 Feb;281(3):739-49. doi: 10.1111/febs.12619. Epub 2013 Dec 10.

    PMID: 24237962BACKGROUND
  • Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2008 Feb 29;283(9):5866-75. doi: 10.1074/jbc.M705092200. Epub 2007 Dec 17.

    PMID: 18089564BACKGROUND
  • Bonewald LF, Johnson ML. Osteocytes, mechanosensing and Wnt signaling. Bone. 2008 Apr;42(4):606-15. doi: 10.1016/j.bone.2007.12.224. Epub 2008 Jan 12.

    PMID: 18280232BACKGROUND
  • Evans RK, Negus CH, Centi AJ, Spiering BA, Kraemer WJ, Nindl BC. Peripheral QCT sector analysis reveals early exercise-induced increases in tibial bone mineral density. J Musculoskelet Neuronal Interact. 2012 Sep;12(3):155-64.

    PMID: 22947547BACKGROUND
  • Hughes JM, Gaffney-Stomberg E, Guerriere KI, Taylor KM, Popp KL, Xu C, Unnikrishnan G, Staab JS, Matheny RW Jr, McClung JP, Reifman J, Bouxsein ML. Changes in tibial bone microarchitecture in female recruits in response to 8 weeks of U.S. Army Basic Combat Training. Bone. 2018 Aug;113:9-16. doi: 10.1016/j.bone.2018.04.021. Epub 2018 Apr 27.

    PMID: 29709620BACKGROUND

Related Links

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Kristen J Koltun, PhD

    University of Pittsburgh

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Vice Chair for Research, Department of Sports Medicine and Nutrition, University of Pittsburgh; Director, Neuromuscular Research Laboratory/Warrior Human Performance Research Center

Study Record Dates

First Submitted

April 28, 2025

First Posted

May 15, 2025

Study Start

August 29, 2022

Primary Completion

April 27, 2025

Study Completion

April 27, 2025

Last Updated

May 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported, after identification (text, tables, figures, and appendices).

Time Frame
Beginning 1 year and ending 5 years following publication.
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. For individual participant data meta-analysis. Proposals should be directed to bnindl@pitt.edu. To gain access, data requesters will need to sign a data access agreement.

Locations